Dr. Ronald Rodriguez, co-founder of the nation’s first MD/MS in Artificial Intelligence dual degree, offers warnings and solutions for generative AI privacy errors, skyrocketing AI usage costs, and AI correcting mistakes resulting in different errors.
AI and other digital tools are easing cognitive burdens for clinicians and enabling leaders to reallocate staff to higher-value tasks, says Whende Carroll, clinical informatics advisor at HIMSS.
At the HIMSS AI in Healthcare Forum, Dennis Chornenky, chief AI advisor at UC Davis Health, discussed the fast-evolving role of AI in healthcare and the urgent need for effective planning and governance. He emphasized that while AI’s potential is vast—from enhancing diagnostics to streamlining administrative tasks—many healthcare organizations are still uncertain about how to manage its challenges responsibly. As AI capabilities expand rapidly, especially with the emergence of agentic AI, healthcare leaders must develop strategies that balance innovation with safety and transparency.
Strengthening chronic disease monitoring, keeping your patients healthier and engaged.
A new study has found that feeding fructose to lab animals with cancer caused their tumors to grow faster. However, the tumors did not directly consume the fructose. Instead, researchers discovered that the liver converted fructose into a type of fat that the cancer cells readily absorbed. This finding sheds light on the potential link between high-fructose diets and tumor growth, an association that has long been suspected but not fully understood. The study, funded by the NIH and published in Nature on December 4, suggests that the liver plays a key role in fueling tumors by transforming fructose into lipids.